Amyris achieved promising in-vivo results for intranasal delivery of RNA/NLC vaccine
On Aug. 20, 2021, Amyris announced promising in-vivo results in a study of its licensed RNA vaccine through…
On Aug. 20, 2021, Amyris announced promising in-vivo results in a study of its licensed RNA vaccine through…
On Aug. 19, 2021, the University of Oxford reported that obtaining two vaccine doses remained the most effective…
On Aug. 19, 2021, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
On Aug. 19, 2021, Oregon Health & Science University (OHSU) announced that it was part of a randomized,…
On Aug. 18, 2021, the final results of the Clinical Trial of COVID-19 Convalescent Plasma in Outpatients (C3PO)…
On Aug. 17, 2021, researchers reported the delta variant of the virus that causes COVID-19 was not particularly…
On Aug. 17, 2021, Our Future Health, announced that it planned to be the UK’s largest health research…
On Aug. 16, 2021, scientists at the National Institutes of Health (NIH) announced they had developed a new…
On Aug. 16, 2021, Moderna announced a revised supply agreement with the Government of Canada for up to…
On Aug. 16, 2021, Pfizer and BioNTech announced that they have submitted Phase 1 data to the U.S….
On Aug. 14, 2021, the Ministry of Health of Cote d’Ivoire confirmed the country’s first case of Ebola…
On Aug. 13, 2021, Merck announced that the U.S. Food and Drug Administration (FDA) had approved WELIREG, an…
On Aug. 13, 2021, Rigel Pharma announced that the U.S. Food and Drug Administration (FDA) had informed the…
On Aug. 13, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved TICOVAC™ (tick-borne…
On Aug. 13, 2021, Moderna announced that the Food and Drug Administration (FDA) had approved an update to…
On Aug. 12, 2021, the U.S. Department of Veterans Affairs (VA) announced that it expanded his previous COVID-19…
On Aug. 12, 2021, Innovation Pharma released information regarding the status of its randomized, double-blind, placebo-controlled Phase 2…
On Aug. 11, 2021, the World Health Organization (WHO) announced the next phase in its Solidarity trial that…
On Aug. 11, 2021, the National Institutes of Health (NIH) announced that one dose of a new monoclonal…
On Aug. 10, 2021, Cardinal Health announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19…
On Aug. 10, 2021, the government of Canada The Government of Canada announced it had established a memorandum…
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
On Aug. 9, 2021, health authorities in Guinea confirmed a case of Marburg virus disease in the southern…
On Aug. 9, 2021, the Therapeutic Goods Administration (TGA), part of the Department of Health, granted provisional approval…
On Aug. 9, 2021, Inovio Pharma announced that it had received regulatory allowance for two clinical trials investigating…
On Aug. 6, 2021, the Centers for Disease Control and Prevention (CDC) announced in MMWR that a study…
On Aug. 6, 2021, the U.S. Food and Drug Administration (FDA) approved Sanofi’s Nexviazyme® (avalglucosidase alfa-ngpt) for the…
On Aug. 6, 2021, BD (Becton, Dickinson) and CerTest Biotec announced the CE mark for a molecular test…
On Aug. 5, 2021, Novavax announced preliminary data demonstrating that a single booster dose of its recombinant nanoparticle…
On Aug. 5, 2021, an international team of researchers announced that a mutation in a single gene appeared…